Company Active LTD

Company profile

Mindlife UK Limited

MindLife - Advanced Solutions to Enhance Life

Advanced Solutions to Enhance Life

CRN
04925936
Founded
2003
Age
22

Overview

Legal name
MINDLIFE UK LIMITED
Region
Unknown
Registered address
LEVEL 9, BERKELEY SQUARE HOUSE
BERKELEY SQUARE
LONDON
ENGLAND
W1J 6BY
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

7 events
31 Jul
2027

Accounts due

Accounts Due

Next accounts due date

27 Dec
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

13 Dec
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Oct
2025

Accounts filed

Accounts

Last accounts made up date

26 Oct
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MTAzMzg0NWFkaXF6a2N4

Published 26 Oct 2024 02:15

12 Aug
2024

Resolution

Resolution

RESOLUTIONS | Transaction QUQ5MDNWNlJhZGlxemtjeA | Paper/PDF filed

Published 13 Aug 2024 07:52

08 Oct
2003

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2020
Funded years
2020, 2023
Age at first award
17 years

Projects

2023 Collaborative R&D Lead participant

UpliftX a digital scalable mental health intervention AI-platform for remote group therapy with personalised client and clinician app

1 Oct 2023 to 30 Sep 2026

Awarded
£479,000
Total cost £684,286

About 1:5 worldwide suffers from mental health problems. Even in the UK there are not enough therapists, and in other countries the situation is much worse. Our team developed the first computerised mental-health application which was approved by NICE for the NHS. However, we have learnt that for most people a combination of a human therapist together wit...

2020 Collaborative R&D Lead participant

EMPATHERAPY: Next generation of PERSONALISED digital, blended and self-help therapy to treat anxiety and depression, and improve wellbeing

1 Nov 2020 to 30 Apr 2021

Awarded
£95,094
Total cost £95,094

At least one in five adults suffer from anxiety, depression, and Covid-19 has increased the population of sufferers. About 7m sufferers are receiving antidepressants and other medications which don't cure them and have side-effects. About 1.6m are referred annually to NHS psychotherapy (called IAPT), mainly face-to-face therapy (until covid-19). However, ...

Product types

Collaborative R&D